Drugs / Monocyte derived DCs loaded with KRN7000
last change May 2011 re-read 3 minutes ago

Monocyte derived DCs loaded with KRN7000

Cell therapy

Developed for
plasma cell myeloma
Investigated by
Celgene Corporation · Kyowa Kirin, Inc. · Yale University

Trials 1

2009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT00698776 Apr 2009 → May 2011 plasma cell myeloma Yale University Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Monocyte derived DCs loaded with KRN7000 ClinicalTrials.gov intervention name — accepted as the source's own label NCT00698776 ↗
Modality Cell therapy “Autologous Mature Dendritic Cells Pulsed With α-galactosyl Ceramide (α-GalCer; KRN7000)” NCT00698776 ↗
Route Intravenous “10 million DCs injected intravenously” NCT00698776 ↗